This mechanism involves increased expression and activity of IR and activated Akt/ GSK-3β signaling, which subsequently enhanced glucose uptake in cardiomyocyte, resulting in improved diabetic cardiomyopathy. The gene discussed is AKT1; the disease is diabetic cardiomyopathy.